NCT00316147 Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules Status COMPLETED Phase PHASE3
NCT00315861 Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00315731 A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT00315380 Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis Status RECRUITING Phase N/A
NCT00315211 Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00314860 RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole Status COMPLETED Phase PHASE3
NCT00314678 Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00312702 Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America Status COMPLETED Phase PHASE1/PHASE2
NCT00312663 Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America Status COMPLETED Phase PHASE1/PHASE2
NCT00312169 Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA) Status COMPLETED Phase N/A
NCT00312013 Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer Status COMPLETED Phase PHASE3
NCT00310388 Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097 Status TERMINATED Phase PHASE3
NCT00310375 Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial Status COMPLETED Phase PHASE3
NCT00309855 Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men Status COMPLETED Phase PHASE1
NCT00309647 Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age Status COMPLETED Phase PHASE1
NCT00309634 Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years Status COMPLETED Phase PHASE1
NCT00309166 Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males. Status COMPLETED Phase PHASE2